Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0016020 | membrane | 2 | 10 |
Related structures:
AlphaFold database: Q4Q3Q5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 56 | 60 | PF00656 | 0.626 |
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.588 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.588 |
CLV_PCSK_SKI1_1 | 109 | 113 | PF00082 | 0.326 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.388 |
DOC_PP1_RVXF_1 | 77 | 84 | PF00149 | 0.551 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.408 |
LIG_14-3-3_CanoR_1 | 109 | 118 | PF00244 | 0.425 |
LIG_14-3-3_CanoR_1 | 126 | 130 | PF00244 | 0.388 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.672 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.604 |
LIG_LIR_Nem_3 | 112 | 118 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 128 | 133 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 77 | 81 | PF02991 | 0.622 |
LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.500 |
LIG_LYPXL_S_1 | 129 | 133 | PF13949 | 0.576 |
LIG_LYPXL_yS_3 | 130 | 133 | PF13949 | 0.378 |
LIG_PCNA_yPIPBox_3 | 97 | 105 | PF02747 | 0.638 |
LIG_PTB_Phospho_1 | 145 | 151 | PF10480 | 0.421 |
LIG_SH2_CRK | 78 | 82 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.540 |
LIG_SH3_3 | 126 | 132 | PF00018 | 0.408 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.637 |
LIG_UBA3_1 | 24 | 30 | PF00899 | 0.497 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.663 |
MOD_CK1_1 | 134 | 140 | PF00069 | 0.510 |
MOD_Cter_Amidation | 124 | 127 | PF01082 | 0.472 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.370 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.673 |
MOD_NEK2_2 | 125 | 130 | PF00069 | 0.358 |
MOD_PIKK_1 | 1 | 7 | PF00454 | 0.558 |
MOD_PIKK_1 | 109 | 115 | PF00454 | 0.464 |
MOD_PKA_1 | 10 | 16 | PF00069 | 0.593 |
MOD_PKA_2 | 125 | 131 | PF00069 | 0.361 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.404 |
TRG_DiLeu_BaEn_1 | 71 | 76 | PF01217 | 0.584 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.378 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.586 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.649 |
TRG_Pf-PMV_PEXEL_1 | 67 | 71 | PF00026 | 0.372 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTD3 | Leptomonas seymouri | 33% | 94% |
A0A0N1PDI5 | Leptomonas seymouri | 66% | 100% |
A0A0S4JQI6 | Bodo saltans | 43% | 100% |
A0A1X0NJU2 | Trypanosomatidae | 28% | 100% |
A0A1X0NR99 | Trypanosomatidae | 46% | 100% |
A0A3S7WP26 | Leishmania donovani | 32% | 90% |
A0A3S7X736 | Leishmania donovani | 90% | 100% |
A0A422N2T1 | Trypanosoma rangeli | 28% | 100% |
A0A422NKR0 | Trypanosoma rangeli | 44% | 100% |
A4H495 | Leishmania braziliensis | 33% | 89% |
A4HLZ1 | Leishmania braziliensis | 85% | 99% |
A4I9C1 | Leishmania infantum | 90% | 100% |
C9ZJA0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
C9ZUD9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
E9AKF5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 90% |
E9B4C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 99% |
V5BJW3 | Trypanosoma cruzi | 24% | 100% |
V5DB75 | Trypanosoma cruzi | 46% | 100% |